Skip to main navigation
Madrigal Pharmaceuticals Madrigal Pharmaceuticals.
  • About Us
    • Overview
    • Leadership
    • Board Of Directors
  • Our Programs
    • Overview
    • Our Medicine
  • NASH
    • Overview
    • Resources
  • Investors & Media
    • Overview
    • Press Releases
    • Events and Presentations
    • Financials and Filings
    • Stock Information
    • Corporate Governance
    • FAQs
    • Email Alerts
  • Careers
    • Join the team
    • Core Values
  • Contact
    • General Inquires
    • Medical Information Inquiries
    • Medical Education Grant Submissions
Search
  • About Us
    • Overview
    • Leadership
    • Board Of Directors
  • Our Programs
    • Overview
    • Our Medicine
  • NASH
    • Overview
    • Resources
  • Investors & Media
    • Overview
    • Press Releases
    • Events and Presentations
    • Financials and Filings
    • Stock Information
    • Corporate Governance
    • FAQs
    • Email Alerts
  • Careers
    • Join the team
    • Core Values
  • Contact
    • General Inquires
    • Medical Information Inquiries
    • Medical Education Grant Submissions
  • Overview
  • Press Releases
  • Events and Presentations
  • Financials and Filings
  • Stock Information
  • Corporate Governance
  • FAQs
  • Email Alerts
Presentations
Fourth-Quarter 2024 Financial Results Presentation
February 26, 2025
Third-Quarter 2024 Financial Results Presentation
October 30, 2024
Second-Quarter 2024 Financial Results Presentation
August 7, 2024
Rezdiffra Approval Presentation
March 14, 2024
Upcoming Events
More events are coming soon.
Archived Events
TD Cowen 45th Annual Health Care Conference
Mar 4, 2025 at 11:10 AM EST
Listen to Webcast
Q4 2024 Earnings Call
Feb 26, 2025 at 8:00 AM EST
Listen to Webcast
Fourth-Quarter 2024 Financial Results Presentation 940.7 KB
Press Release 376.3 KB
43rd Annual J.P. Morgan Healthcare Conference
Jan 15, 2025 at 5:15 PM EST
Listen to Webcast
Press Release 804.7 KB
43rd Annual J.P. Morgan Healthcare Presentation 1.3 MB
Piper Sandler 36th Annual Healthcare Conference
Dec 5, 2024 at 8:30 AM EST
Listen to Webcast
7th Annual Evercore HealthCONx Conference
Dec 4, 2024 at 9:35 AM EST
Listen to Webcast
UBS Global Healthcare Conference 2024
Nov 13, 2024 at 2:00 PM EST
Listen to Webcast
Q3 2024 Earnings Call
Oct 31, 2024 at 8:00 AM EDT
Listen to Webcast
Third-Quarter 2024 Financial Results Presentation 375.7 KB
Press Release 118.1 KB
H.C. Wainwright & Co. 8th Annual MASH Investor Conference
Oct 7, 2024 at 2:00 PM EDT
Listen to Webcast

Madrigal’s ambitious research programs led to the first FDA-approved treatment in NASH.

Learn More
Madrigal Pharmaceuticals. Logo

Madrigal Pharmaceuticals

200 Barr Harbor Drive,
Suite 200

West Conshohocken,
Pennsylvania 19428

  • About Us
  • Our Programs
  • NASH
  • Investors & Media
  • Careers
  • Contact
Madrigal Pharmaceuticals
  • Terms of Use
  • Privacy
  • Cookies
  • ETHICS and COMPLIANCE
  • TRANSPARENCY
©2025 Madrigal Pharmaceuticals. All rights reserved.